. Computed tomography scan demonstrating a 2 3 4-cm mass abutting the anterior tail of the left parotid gland.
A small percentage of parotid tumors (from 1.0%-7.7%) occurs in accessory parotid gland tissue, defined as salivary gland tissue adjacent to Stensen's duct and separate from the main body of the parotid gland. 1, 2 Salivary duct carcinoma is a rare neoplasm, comprising 1% of salivary gland malignancies. 3 We present herein the first case reported in the English literature of a salivary duct carcinoma of the accessory parotid gland.
Case Presentation
A 76-year-old woman was referred to our clinic for a 3month history of a firm, enlarging mass of her left cheek. Physical examination revealed a 3-cm mass, mobile in her mid-cheek. Fine-needle aspiration biopsy was consistent with a poorly differentiated carcinoma that could not be further delineated. A computed tomography (CT) scan demonstrated a large heterogeneously enhancing, poorly marginated, lobulated mass anterior to the main parotid gland and abutting the masseter muscle. No pathological-appearing nodes were visualized (see Figure 1) .
The patient underwent a left parotidectomy via a modified Blair incision. The tumor was a 5 3 4 3 4-cm smooth mass abutting the masseter and extending toward the anterior wall of the maxillary sinus. It was distinct from the main body of the parotid gland. Histology demonstrated tumor cells arranged in cribriform, papillary, and solid patterns (see Figure 2 ) characteristic of salivary duct carcinoma. The patient declined adjuvant radiation therapy, and she died 2 years later after being admitted to the hospital for sepsis.
Exemption from review was obtained from the Institutional Review Board of the University of California, Davis.
Discussion
Salivary duct carcinoma is a rare and aggressive malignancy comprising 1% of salivary carcinomas and is most commonly found in the parotid gland. It typically presents as a rapidly enlarging mass with facial nerve weakness and regional lymph node metastasis. Local and regional recurrences occur in 30% and 60%, respectively. Fifty percent of patients will develop distant metastases, and 5-year survival is estimated at 50%. 3 Tumors of the accessory parotid gland have been reported as 1% to 7.7% of parotid tumors. 1,2 A high degree of suspicion is needed to not overlook a tumor of the accessory gland during the workup of a mid-cheek mass. A thorough physical examination along with fine-needle aspiration biopsy and CT scanning are the mainstays of workup. 4 The standard parotidectomy remains the general accepted surgical approach due to lower rates of facial nerve injury and tumor recurrence. 1, 2, 4, 5 Superior or inferior extension of this incision is further advocated if necessary for better visualization. 4 Transfacial or transoral approaches through the buccal mucosa are generally not advised due to difficulties of exposure and facial nerve identification. 1, 5 It is thought that small (T1 and T2) low-grade malignancies may be sufficiently managed by wide excision without concomitant parotidectomy because the accessory parotid gland is an independent island of salivary tissue. High-grade malignancies, large tumor size, or locoregional spread are indications for total parotidectomy and neck dissection. Complications from surgery are similar to that of a standard parotidectomy, with the possibility of hematoma, seroma, facial nerve injury, salivary fistula, and tumor recurrence. Similar to its role in the management of other salivary gland malignancies, adjuvant postoperative radiation therapy is typically reserved for high-grade malignancies and advanced-stage disease. 4 
Conclusion
We present a previously unreported case of salivary duct carcinoma of the accessory parotid gland. An accessory parotid tumor should be considered in the differential of a midcheek mass with workup for a salivary gland malignancy. Lower rates of facial nerve injury and tumor recurrence are noted with a standard parotidectomy incision compared with direct cheek or perioral approaches. 
